Published in Women's Health Weekly, March 15th, 2007
Medical investigators at Erasmus Cancer Center have demonstrated that a high HOXB13-to-IL17BR ('H over I" or H/I)...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.